GOLETA, Calif.–(BUSINESS WIRE)– Inogen,
Inc. (NASDAQ: INGN),
a medical technology company offering innovative respiratory products
for use in the homecare setting, announced today that it will be
participating in two upcoming investor conferences.
Inogen’s President and COO, Scott Wilkinson and CFO, Alison Bauerlein,
are scheduled to present at the J.P. Morgan 35th Annual Healthcare
Conference in San Francisco on Tuesday, January 10, 2017 at 4:00pm PT.
Mr. Wilkinson is also scheduled to present at the 19th Annual Needham &
Company Growth Conference in New York City on Thursday, January 12, 2017
at 10:00am ET.
Interested parties can access the live audio webcast for both of these
conference presentations from the Events section of the Investor
Relations page on the Inogen website at www.inogen.com.
Both webcast replays will be available approximately one hour after the
conclusion of the live presentations and will remain available for
approximately 90 days.
Inogen has used, and intends to continue to use, its Investor Relations
website, http://investor.inogen.com/,
as a means of disclosing material non-public information and for
complying with its disclosure obligations under Regulation FD. For more
information, visit http://investor.inogen.com/.
About Inogen
Inogen is innovation in oxygen therapy. We are a medical technology
company that develops, manufactures and markets innovative oxygen
concentrators used to deliver supplemental long-term oxygen therapy to
patients suffering from chronic respiratory conditions.
For more information, please visit www.inogen.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161221005829/en/
Contacts
Inogen, Inc.
Investor Relations Contact:
ir@inogen.net
805-562-0500
ext. 7
or
Media Contact:
Byron Myers
805-562-0503
Source: Inogen, Inc.
Cet article Inogen to Participate in Upcoming Investor Conferences est apparu en premier sur EEI-BIOTECHFINANCES.